Repeat Disorders
STR: SAMD12_FAME1_TTTCA
NC_000008.10:g.119379055_119379157TGAAA[X]TAAAA[X]
A heterozygous or homozygous 5-bp expanded TTTCA(n) insertion associated with an upstream 5-bp TTTTA(n) repeat expansion in a noncoding region within intron 4 of the SAMD12 gene, was identified in over 50 Chinese and Japanese families. 4 homozygous cases from 3 families had a more severe phenotype. The TTTTA repeat was present in controls, while the TTTCA was absent and only present in cases (100-3680 repeats reported). RNA toxicity is expected to be the mechanism of disease.
Sources: Expert listCreated: 29 Aug 2021, 2:50 a.m. | Last Modified: 29 Aug 2021, 3:30 a.m.
Panel Version: 0.95
Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Phenotypes
Epilepsy, familial adult myoclonic, 1 MIM#601068
Publications
Clinically RelevantInterruptions in the repeated sequence are reported as part of standard diagnostic practise
FAME1 was changed to SAMD12_FAME1_TTTCA
Tag adult-onset tag was added to STR: FAME1.
Str: fame1 has been classified as Green List (High Evidence).
Str: fame1 has been classified as Green List (High Evidence).
STR: FAME1 was added STR: FAME1 was added to Repeat Disorders. Sources: Expert list Mode of inheritance for STR: FAME1 was set to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal Publications for STR: FAME1 were set to 30194086; 29507423 Phenotypes for STR: FAME1 were set to Epilepsy, familial adult myoclonic, 1 MIM#601068 Review for STR: FAME1 was set to GREEN STR: FAME1 was marked as clinically relevant